Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune Responses.
Chikungunya virus (CHIKV) and other alphaviruses are the etiologic agents of numerous diseases in both humans and animals. Despite this, the viral mediators of protective immunity against alphaviruses are poorly understood, highlighted by the lack of a licensed human vaccine for any member of this v...
Saved in:
Main Authors: | James Weger-Lucarelli (Author), Matthew T Aliota (Author), Attapon Kamlangdee (Author), Jorge E Osorio (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.
by: James Weger-Lucarelli, et al.
Published: (2014) -
Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.
by: John M Powers, et al.
Published: (2021) -
Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein.
by: John M Powers, et al.
Published: (2023) -
Variable effects of transient Wolbachia infections on alphaviruses in Aedes aegypti.
by: Brittany L Dodson, et al.
Published: (2024) -
Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas.
by: Naomi L Forrester, et al.
Published: (2017)